Showing results (61-70 of 105) with videos related to
Sort By:
Pageof 11
Nature Communications|January 23, 2015
Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumoursKevin Litchfield, Brenda Summersgill, Shawn Yost, et al.Cancer Research|October 19, 2005
Association between large-scale genomic homozygosity without chromosomal loss and nonseminomatous germ cell tumor developmentYong-Jie Lu, Jinshu Yang, Elodie Noel, et al.Lung Cancer (Amsterdam, Netherlands)|August 30, 2006
Nuclear overexpression of the E2F3 transcription factor in human lung cancerColin S Cooper, Andrew G Nicholson, Christopher Foster, et al.Cancer Research|October 20, 2004
A gene expression signature associated with metastatic outcome in human leiomyosarcomasYin-Fai Lee, Megan John, Alison Falconer, et al.Nature Communications|October 28, 2015
Identification of four new susceptibility loci for testicular germ cell tumourKevin Litchfield, Amy Holroyd, Amy Lloyd, et al.Clinical Epigenetics|October 20, 2023
Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cellsEleanor O'Brien, Carmen Tse, Ian Tracy, et al.Cancer Research|September 17, 2005
Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adultsAlan McIntyre, Brenda Summersgill, Beata Grygalewicz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivoJane Renshaw, Kathryn R Taylor, Ryan Bishop, et al.Pediatric Blood & Cancer|November 8, 2024
Clinicopathological Analysis of a European Cohort of MYOD1 Mutant Rhabdomyosarcomas in Children and Young AdultsJulia C Chisholm, Joanna L Selfe, Rita Alaggio, et al.Cancer|May 26, 2018
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Soledad Gallego, Ilaria Zanetti, Daniel Orbach, et al.Pageof 11